Skip to main content
Clinical Trials/NCT06424925
NCT06424925
Not yet recruiting
Not Applicable

Use of Artificial Intelligence (AI) for the Prediction of Clinical Outcomes Such as Death and Complications in Patients Hospitalized for COVID Pneumonia During the 4 Pandemic Waves at the ASST of Lecco.

Azienda Ospedaliera di Lecco1 site in 1 country5,000 target enrollmentJune 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COVID-19 Pandemic
Sponsor
Azienda Ospedaliera di Lecco
Enrollment
5000
Locations
1
Primary Endpoint
Construction of predictive models
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

Predictive models can be applied in different areas, during the emergency of the COVID-19 pandemic, in fact, they have proven important in supporting health systems in planning strategic decisions and in formulating health policies for the containment of the disease.

The Covid-19 pandemic, in particular, has represented a real challenge for our healthcare system. In Italy, it was divided into four main waves, each characterized by different types of patients and different therapeutic approaches progressively improved based on new scientific evidence.

The objective is to carry out a study on the data of patients hospitalized for COVID-19 at the ASST of Lecco during all four pandemic waves, with different degrees of severity of illness, collecting the data of interest and applying it to they use artificial intelligence to identify recurring patterns of clinical outcome in terms of survival and secondary infectious complications, so as to build new reliable predictive statistical models that can be used to predict the outcome of the patients themselves.

The strong ambition of this project is that the application of artificial intelligence to data of such significant quantity can allow us to build valid statistical models which can then be hypothetically applied to any patient to predict, based on anamnestic characteristics, blood chemical parameters. at baseline and at the set treatment, the probability of survival and complications

Registry
clinicaltrials.gov
Start Date
June 1, 2024
End Date
December 31, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Azienda Ospedaliera di Lecco
Responsible Party
Principal Investigator
Principal Investigator

Stefania Piconi

Director of Infectious Diseases Unit

Azienda Ospedaliera di Lecco

Eligibility Criteria

Inclusion Criteria

  • Age \> 18 years;
  • Hospitalization for COVID-19 pneumonia at ASST Lecco.

Exclusion Criteria

  • Hospitalization or finding of asymptomatic SARS CoV-2 infection.

Outcomes

Primary Outcomes

Construction of predictive models

Time Frame: 6 months

Construction of predictive models to evaluate clinical outcomes such as death and/or onset of secondary infection based on the data collected relating to the 4 COVID-19 waves.

Study Sites (1)

Loading locations...

Similar Trials